Robeco Institutional Asset Management
ACOR

Robeco Institutional Asset Management’s Acorda Therapeutics ACOR Stock Holding History

Robeco Institutional Asset Management’s Portfolio ACOR Stock Details ACOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-32
Closed -$11K – 1009
2019
Q3 		$11K Sell
32
-1,000
-97% -$544K ﹤0.01% 958
2019
Q2 		$949K Sell
1,032
-300
-23% -$369K ﹤0.01% 778
2019
Q1 		$2.13M Buy
1,332
+379
+40% +$683K 0.01% 700
2018
Q4 		$1.76M Buy
+953
New +$2.07M 0.01% 688

Other funds holding ACOR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Robeco Institutional Asset Management's ACOR Position: Q4 2019 in Review

Robeco Institutional Asset Management sold out of Acorda Therapeutics (ACOR) in Q4 2019, closing a stake of 32 shares — an estimated $11K sold.

Robeco Institutional Asset Management first reported a position in ACOR in Q4 2018 and held it in 4 quarters. The position peaked at $2.13M in Q1 2019. 121 funds tracked by Wall St. Rank hold ACOR as of Q4 2019.

  • Robeco Institutional Asset Management reported no remaining Acorda Therapeutics position as of Q4 2019 after selling out during the quarter.
  • Robeco Institutional Asset Management sold 32 Acorda Therapeutics shares in Q4 2019, an estimated $11K.
  • Robeco Institutional Asset Management first reported a position in Acorda Therapeutics in Q4 2018 and held it in 4 quarters.
  • Robeco Institutional Asset Management's Acorda Therapeutics position peaked at $2.13M in Q1 2019.
  • 121 funds tracked by Wall St. Rank held Acorda Therapeutics as of Q4 2019.

Based on Robeco Institutional Asset Management's 13F filing for Q4 2019, filed 6 Feb 2020.